Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Narra J

Effects of cholecalciferol supplementation on depressive symptoms, C-peptide, serotonin, and neurotrophin-3 in type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial Putranto, Rudi; Setiati, Siti; Nasrun, Martina W.; Witjaksono, Fiastuti; Immanuel, Suzanna; Subekti, Imam; Harimurti, Kuntjoro; Siswanto, Agus; Shatri, Hamzah; Suwarto, Suhendro; Megantara, Marcelino A.
Narra J Vol. 4 No. 3 (2024): December 2024
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v4i3.1342

Abstract

The coexistence of depression and type 2 diabetes mellitus (T2DM) can significantly worsen disease prognosis and lower quality of life. Emerging evidence suggests that vitamin D deficiency contributes to the progression of T2DM and is closely associated with the development of depression. The aim of this study was to investigate the effects of cholecalciferol on depression in patients with T2DM, exploring its mechanisms by analyzing its impact on C-peptide, serotonin, and neurotrophin-3 levels. A double-blind, randomized, placebo-controlled clinical trial was conducted at Cipto Mangunkusumo General Hospital, Jakarta, Indonesia, from April 2021 to September 2022. Patients with T2DM and depressive symptoms were randomly assigned to two groups: received 4000 IU of cholecalciferol daily and received a placebo for 12 weeks. Depression was assessed using the Beck Depression Inventory-II (BDI-II) before and 12 weeks after the intervention. The levels of C-peptide, serotonin, and neurotrophin-3 were measured at the end of the fourth week of intervention using the enzyme-linked immunosorbent assay (ELISA) method. Between-group comparisons were made using independent Student t-tests and Mann-Whitney U tests. Paired Student t-tests or Wilcoxon tests were applied for within-group comparisons between pre- and post-intervention. A total of 70 T2DM patients with depression were included in this study, comprising 38 patients in the cholecalciferol group and 32 in the placebo group. C-peptide levels increased significantly in the cholecalciferol group compared to the placebo group (p=0.006). No significant differences were observed in serotonin and NT-3 levels between the cholecalciferol group compared to the placebo group. The cholecalciferol group had a significantly greater reduction in BDI-II scores compared to the placebo group (p<0.001). This trial highlights that taking cholecalciferol might help ease mild to moderate depression symptoms in patients with T2DM by enhancing c-peptide levels, though its effects on serotonin and neurotrophin-3 are still unclear.
Validity and reliability testing of the Shatri Sinulingga psychosomatic test (SSPT) questionnaire as a screening instrument for psychosomatic disorders in Indonesia Shatri, Hamzah; Sinulingga, Dika I.; Faisal, Edward; Irvianita, Vinandia; Putranto, Rudi; Ardani, Yanuar; Erlita, Diana; Jeger, Dian P.; Browijoyo, Isa A.
Narra J Vol. 4 No. 3 (2024): December 2024
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v4i3.1373

Abstract

The incidence of psychosomatic disorders is increasing in Indonesia, and therefore screening instruments that are culturally appropriate for the Indonesian population are needed. The aim of this study was to assess the validity and reliability of the Shatri Sinulingga psychosomatic test (SSPT) questionnaire as a screening instrument for psychosomatic disorders in Indonesia. An analytic descriptive cross-sectional study divided into two stages (questionnaire formulation and distribution through the Psikosom.id application) was conducted in 2023. The validity test was carried out using the product moment technique, and Cronbach's alpha assessment was carried out to evaluate the reliability of the questionnaire. A total of 372 participants were included, with a mean age of 39.24 years old. The SSPT questionnaire scores had strong correlations with the scores of hospital anxiety and depression scale (HADS) (r=0.668; p<0.001) and the Symptom Checklist-90 (SCL-90) (r=0.674; p<0.001); and moderately correlated with the score of fatigue severity scale (FSS) (r=0.505; p<0.001) and Pittsburgh Sleep Quality Index (PSQI) (r=0.492; p<0.001). The correlation coefficient (r) value of each SSPT question ranged from 0.389–0.726, and all r higher than r table with an overall Cronbach’s alpha of 0.744. The SSPT questionnaire's strong predictive performance: had a sensitivity of 75.6% and specificity of 71.4% with an area under the curve (AUC) of 81% (95%CI: 76.6–85.4%; p<0.001) to HADS; sensitivity of 80% and specificity of 58.6% with an AUC of 75.1% (95%CI: 70–80.2%; p<0.001) to FSS; sensitivity of 64% and specificity of 67.5% with an AUC of 71.2% (95%CI:  65.4–77%; p<0.001) to PSQI; and had sensitivity of 78% and specificity of 67.4% with an AUC of 80.9% (95%CI:  76.6–85.3%; p<0.001) to SCL-90. The study highlights that the SSPT questionnaire is valid and reliable to be used as a screening instrument for psychosomatic disorders in Indonesia.
Co-Authors Achmad Fauzi Achmad Fauzy, Achmad Adhiatma, Kresna Adityo Susilo, Adityo Adli, Mizanul Afistianto, Muhammad Fikri Agus Siswanto Agustin Kusumayati Ahani, Ardhi Rahman Alexander, Reinaldo Alfiah, Elma Alvina Widhani, Alvina Andru, Gestana Anwar, Bariani Anwar, Sufyan Ardani, Yanuar Ardhi Rahman Ahani Arfah Husna Ari Fahrial Syam Ari Fahrial Syam Arif Mansjoer Arshita Auliana Aulia Rizka, Aulia Badriul Hegar Bambang Setyohadi Bambang Setyohadi Bambang Subangkit Browijoyo, Isa A. Budi Sampurna Chairani, Aisha Putri Chyntia Olivia Maurine Jasirwan, Chyntia Olivia Maurine Cleopas Martin Rumende Cophiadi Irawan Cosphiadi Irawan Dadang Makmun Diah Martina, Diah Dono Antono E. Mudjaddid A. Siswanto Deddy N.W.Achadiono Hamzah Shatri Eddy Mart Salim, Eddy Mart Edward Faisal Edward Faisal Eka Ginanjar Em Yunir, Em Erlita, Diana Evy Yunihastuti Faisal, Edward Fiastuti Witjaksono Fita Fitrianti Fitrawan, Ahmad Frastica, Michelle Hapsari, Aljira Fitya Harna, Harna Harry Isbagio Hasan Maulahela Herqutanto - Ika Prasetya Wijaya Ikhwan Rinaldi Imam Subekti Iris Rengganis Irman Firmansyah Irvianita, Vinandia Iskandar Iskandar Jeger, Dian P. Jufri , Jufri Kambang Sariadji Kamilia, Nisrina Kemal Fariz Kalista, Kemal Fariz Kosasih, Kartika Anastasia Kuntjoro Harimurti Kurniawan , Ade Laksono Trisnantoro Leonard Nainggolan Luxi Riajuni Marbun, Maruhum Bonar Hasiholan Marcellus Simadibrata Marniati Marniati, Marniati Megantara, Marcelino A. Muh Asrul Irawan, Andi Muhadi Muhadi, Muhadi Muhammad Ali Apriansyah, Muhammad Ali Murdani Abdullah Nabil Mubtadi Falah Nabil Mubtadi Falah, Nabil Mubtadi Nasrun, Martina W. Natali, Veritea nFN Abdurrahman, nFN nFN Sunarno, nFN Noer Endah Pracoyo Noto Dwimartutie Novita, Anisah Nurfitria, Nandika Nurrahmah , Awalia Pane, Meivina Ramadhani Poespitasari, Vinandya Irvianita Pratama, Metra Adi Pringgodigdo Nugroho, Pringgodigdo Putri, Enda Silvia Rachmawati, Elvie Zulka Autzia Raniah, Nida Ratih Arianita Agung Restuti, Ratna Dwi Sabililhaq, Muhammad Adnan Sabrina Munggarani Yusuf Sally A Nasution, Sally A Sariadji Kambang, Sariadji Sihwastuti, Sihwastuti Sinulingga, Dika Sinulingga, Dika I. Siti Setiati Suhendro Suwarto, Suhendro Sukamto Koesnoe Sumariyono Sumariyono Sunarno - Suzanna Immanuel Su’udi, Amir Syahrani, Aisyah Syamsuar Manyullei Tri Juli Edi Tarigan Triyani Sukarso Ukkas, Ummu Kalsum Wismandari Wisnu Wulyo Rajabto Yos Hendra Yos Hendra, Yos Yunizaf, Rahmanofa Yusuf, Andi Mukramin Zulkifly, Steven